T/CACM 1231-2019 Active Group standards

T/CACM 1231-2019 Chinese Internal Medicine Clinical Guidelines for the Diagnosis and Treatment of Cardiovascular Diseases (Hypertensive Left Ventricular Hypertrophy)

Publish Date: 2019-01-30 Implement Date: 2020-01-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/CACM 1231-2019

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: Medicine

ICS Name: Comprehensive Pharmaceutical Science

Publish Date: 2019-01-30

Implement Date: 2020-01-01

Scope

Main technical content: This guideline introduces the common causes of left ventricular hypertrophy in hypertension, the law of symptom development, differential diagnosis and treatment, and prognosis (based on the use of Western medicine for blood pressure reduction), and proposes recommendations for the diagnosis, differential diagnosis, and treatment of left ventricular hypertrophy in hypertension. This guideline is suitable for the diagnosis and treatment of left ventricular hypertrophy in people aged 18 and above. This guideline is suitable for clinical internists, especially cardiologists, to use.